BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crooke SN, Ovsyannikova IG, Kennedy RB, Poland GA. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome. Sci Rep 2020;10:14179. [PMID: 32843695 DOI: 10.1038/s41598-020-70864-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Devi SS, Kardam V, Dubey KD, Dwivedi M. Deciphering the immunogenic T-cell epitopes from spike protein of SARS-CoV-2 concerning the diverse population of India. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2037462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chakraborty C, Sharma AR, Bhattacharya M, Lee SS. Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research. Int J Pept Res Ther 2021;:1-9. [PMID: 34276266 DOI: 10.1007/s10989-021-10254-4] [Reference Citation Analysis]
3 Yang CH, Li HC, Lee WH, Lo SY. Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants. Pathogens 2021;10:869. [PMID: 34358019 DOI: 10.3390/pathogens10070869] [Reference Citation Analysis]
4 Plūme J, Galvanovskis A, Šmite S, Romanchikova N, Zayakin P, Linē A. Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03382-y] [Reference Citation Analysis]
5 Devaux CA, Pinault L, Delerce J, Raoult D, Levasseur A, Frutos R. Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution. Front Microbiol 2021;12:675528. [PMID: 34616371 DOI: 10.3389/fmicb.2021.675528] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nel AE, Miller JF. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape. ACS Nano 2021;15:5793-818. [PMID: 33793189 DOI: 10.1021/acsnano.1c01845] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
7 Heffron AS, McIlwain SJ, Amjadi MF, Baker DA, Khullar S, Sethi AK, Palmenberg AC, Shelef MA, O'Connor DH, Ong IM. The landscape of antibody binding in SARS-CoV-2 infection. bioRxiv 2021:2020. [PMID: 33052349 DOI: 10.1101/2020.10.10.334292] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Ghosh N, Sharma N, Saha I, Saha S. Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity. Int Immunopharmacol 2021;91:107276. [PMID: 33385714 DOI: 10.1016/j.intimp.2020.107276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vasina M, Velecký J, Planas-Iglesias J, Marques SM, Skarupova J, Damborsky J, Bednar D, Mazurenko S, Prokop Z. Tools for computational design and high-throughput screening of therapeutic enzymes. Adv Drug Deliv Rev 2022;183:114143. [PMID: 35167900 DOI: 10.1016/j.addr.2022.114143] [Reference Citation Analysis]
10 Camerini D, Randall AZ, Trappl-Kimmons K, Oberai A, Hung C, Edgar J, Shandling A, Huynh V, Teng AA, Hermanson G, Pablo JV, Stumpf MM, Lester SN, Harcourt J, Tamin A, Rasheed M, Thornburg NJ, Satheshkumar PS, Liang X, Kennedy RB, Yee A, Townsend M, Campo JJ. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray. Microbiol Spectr 2021;9:e0141621. [PMID: 34704808 DOI: 10.1128/Spectrum.01416-21] [Reference Citation Analysis]
11 Zhao J, Wang L, Schank M, Dang X, Lu Z, Cao D, Khanal S, Nguyen LN, Nguyen LNT, Zhang J, Zhang Y, Adkins JL, Baird EM, Wu XY, Ning S, Gazzar ME, Moorman JP, Yao ZQ. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects. Virus Res 2021;304:198508. [PMID: 34329696 DOI: 10.1016/j.virusres.2021.198508] [Reference Citation Analysis]
12 Poland GA, Ovsyannikova IG, Kennedy RB. The need for broadly protective COVID-19 vaccines: Beyond S-only approaches. Vaccine 2021;39:4239-41. [PMID: 34167836 DOI: 10.1016/j.vaccine.2021.06.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jahangirian E, Jamal GA, Nouroozi M, Mohammadpour A. A Novel Multiepitope Vaccine Against Bladder Cancer Based on CTL and HTL Epitopes for Induction of Strong Immune Using Immunoinformatics Approaches. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10380-7] [Reference Citation Analysis]
14 Abdoli A, Aalizadeh R, Aminianfar H, Kianmehr Z, Teimoori A, Azimi E, Emamipour N, Eghtedardoost M, Siavashi V, Jamshidi H, Hosseinpour M, Taqavian M, Jalili H. Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study. Rev Med Virol 2021;:e2305. [PMID: 34699647 DOI: 10.1002/rmv.2305] [Reference Citation Analysis]
15 Oliveira SC, de Magalhães MTQ, Homan EJ. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets. Front Immunol 2020;11:587615. [PMID: 33193414 DOI: 10.3389/fimmu.2020.587615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
16 Ha B, Jadhao S, Hussaini L, Gibson T, Stephens K, Salazar L, Ciric C, Taylor M, Rouphael N, Edupuganti S, Rostad CA, Tompkins SM, Anderson EJ, Anderson LJ. Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera. Microbiol Spectr 2021;9:e0045821. [PMID: 34494855 DOI: 10.1128/Spectrum.00458-21] [Reference Citation Analysis]
17 Singh J, Malik D, Raina A. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus. Vaccine 2021;39:1087-95. [PMID: 33478787 DOI: 10.1016/j.vaccine.2021.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Bukhari SNH, Jain A, Haq E, Mehbodniya A, Webber J. Machine Learning Techniques for the Prediction of B-Cell and T-Cell Epitopes as Potential Vaccine Targets with a Specific Focus on SARS-CoV-2 Pathogen: A Review. Pathogens 2022;11:146. [DOI: 10.3390/pathogens11020146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Pagano S, Yerly S, Meyer B, Juillard C, Suh N, Le Terrier C, Daguer JP, Farrera-Soler L, Barluenga S, Piumatti G, Hartley O, Lemaitre B, Eberhardt CS, Siegrist CA, Eckerle I, Stringhini S, Guessous I, Kaiser L, Pugin J, Winssinger N, Vuilleumier N. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. Eur J Clin Invest 2021;:e13661. [PMID: 34324704 DOI: 10.1111/eci.13661] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Hamley IW. Peptides for Vaccine Development. ACS Appl Bio Mater 2022. [PMID: 35195008 DOI: 10.1021/acsabm.1c01238] [Reference Citation Analysis]
21 Poland GA, Ovsyannikova IG, Crooke SN, Kennedy RB. SARS-CoV-2 Vaccine Development: Current Status. Mayo Clin Proc 2020;95:2172-88. [PMID: 33012348 DOI: 10.1016/j.mayocp.2020.07.021] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 23.5] [Reference Citation Analysis]
22 Moore T, Hossain R, Doores KJ, Shankar-Hari M, Fear DJ. SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination. Viral Immunol 2022. [PMID: 35857310 DOI: 10.1089/vim.2022.0013] [Reference Citation Analysis]
23 Kumar N, Admane N, Kumari A, Sood D, Grover S, Prajapati VK, Chandra R, Grover A. Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework. Sci Rep 2021;11:7653. [PMID: 33828130 DOI: 10.1038/s41598-021-86986-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Nakamura T, Isoda N, Sakoda Y, Harashima H. Strategies for fighting pandemic virus infections: Integration of virology and drug delivery. J Control Release 2022:S0168-3659(22)00068-2. [PMID: 35122872 DOI: 10.1016/j.jconrel.2022.01.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Prakash S, Srivastava R, Coulon PG, Dhanushkodi NR, Chentoufi AA, Tifrea DF, Edwards RA, Figueroa CJ, Schubl SD, Hsieh L, Buchmeier MJ, Bouziane M, Nesburn AB, Kuppermann BD, BenMohamed L. Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines. J Immunol 2021;206:2566-82. [PMID: 33911008 DOI: 10.4049/jimmunol.2001438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
26 Prakash S, Srivastava R, Coulon PG, Dhanushkodi NR, Chentoufi AA, Tifrea DF, Edwards RA, Figueroa CJ, Schubl SD, Hsieh L, Buchmeier MJ, Bouziane M, Nesburn AB, Kuppermann BD, BenMohamed L. Genome-Wide Asymptomatic B-Cell, CD4 + and CD8 + T-Cell Epitopes, that are Highly Conserved Between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Immune Targets for Pre-Emptive Pan-Coronavirus Vaccines. bioRxiv 2020:2020. [PMID: 33024971 DOI: 10.1101/2020.09.27.316018] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Akbay B, Abidi SH, Ibrahim MAA, Mukhatayev Z, Ali S. Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes. Vaccines (Basel) 2021;9:702. [PMID: 34206865 DOI: 10.3390/vaccines9070702] [Reference Citation Analysis]
28 Bukhari SNH, Jain A, Haq E, Mehbodniya A, Webber J. Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets. Diagnostics (Basel) 2021;11:1990. [PMID: 34829338 DOI: 10.3390/diagnostics11111990] [Reference Citation Analysis]
29 Sohail MS, Ahmed SF, Quadeer AA, McKay MR. In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives. Adv Drug Deliv Rev 2021;171:29-47. [PMID: 33465451 DOI: 10.1016/j.addr.2021.01.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 33.0] [Reference Citation Analysis]
30 Gustiananda M, Sulistyo BP, Agustriawan D, Andarini S. Immunoinformatics Analysis of SARS-CoV-2 ORF1ab Polyproteins to Identify Promiscuous and Highly Conserved T-Cell Epitopes to Formulate Vaccine for Indonesia and the World Population. Vaccines (Basel) 2021;9:1459. [PMID: 34960205 DOI: 10.3390/vaccines9121459] [Reference Citation Analysis]
31 Sharma A, Virmani T, Pathak V, Sharma A, Pathak K, Kumar G, Pathak D. Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine. Biomed Res Int 2022;2022:7205241. [PMID: 35845955 DOI: 10.1155/2022/7205241] [Reference Citation Analysis]
32 Heffron AS, McIlwain SJ, Amjadi MF, Baker DA, Khullar S, Armbrust T, Halfmann PJ, Kawaoka Y, Sethi AK, Palmenberg AC, Shelef MA, O'Connor DH, Ong IM. The landscape of antibody binding in SARS-CoV-2 infection. PLoS Biol 2021;19:e3001265. [PMID: 34143766 DOI: 10.1371/journal.pbio.3001265] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Quach HQ, Ovsyannikova IG, Poland GA, Kennedy RB. Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA. Journal of Immunological Methods 2022. [DOI: 10.1016/j.jim.2022.113275] [Reference Citation Analysis]
34 Carneiro DC, Sousa JD, Monteiro-Cunha JP. The COVID-19 vaccine development: A pandemic paradigm. Virus Res 2021;301:198454. [PMID: 34015363 DOI: 10.1016/j.virusres.2021.198454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Somogyi E, Csiszovszki Z, Molnár L, Lőrincz O, Tóth J, Pattijn S, Schockaert J, Mazy A, Miklós I, Pántya K, Páles P, Tőke ER. A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects. Front Genet 2021;12:684152. [PMID: 34249101 DOI: 10.3389/fgene.2021.684152] [Reference Citation Analysis]
36 Devi YD, Goswami HB, Konwar S, Doley C, Dolley A, Devi A, Chongtham C, Dowerah D, Biswa V, Jamir L, Kumar A, Satapathy SS, Ray SK, Deka RC, Doley R, Mandal M, Das S, Singh CS, Borah PP, Nath P, Namsa ND. Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins. PLoS One 2021;16:e0258645. [PMID: 34780495 DOI: 10.1371/journal.pone.0258645] [Reference Citation Analysis]
37 Uttamrao PP, Sathyaseelan C, Patro LPP, Rathinavelan T. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach. Front Immunol 2021;12:692937. [PMID: 34497604 DOI: 10.3389/fimmu.2021.692937] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Behmard E, Soleymani B, Najafi A, Barzegari E. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2. Sci Rep 2020;10:20864. [PMID: 33257716 DOI: 10.1038/s41598-020-77547-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
39 Chen J, Deng Y, Huang B, Han D, Wang W, Huang M, Zhai C, Zhao Z, Yang R, Zhao Y, Wang W, Zhai D, Tan W. DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice. Front Immunol 2022;13:827605. [PMID: 35281016 DOI: 10.3389/fimmu.2022.827605] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 Ferreira CS, Martins YC, Souza RC, Vasconcelos ATR. EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes. PeerJ 2021;9:e12548. [PMID: 34909278 DOI: 10.7717/peerj.12548] [Reference Citation Analysis]
41 Ghosh N, Sharma N, Saha I. Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes. Infect Genet Evol 2021;92:104823. [PMID: 33819681 DOI: 10.1016/j.meegid.2021.104823] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Piccialli F, di Cola VS, Giampaolo F, Cuomo S. The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic. Inf Syst Front 2021;:1-31. [PMID: 33935585 DOI: 10.1007/s10796-021-10131-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]